Main Article Content

Fabián Córdoba Anaya
Dariana Loaiza Zúñiga
María Gina Cuello


Breast cancer, epidemiology, public health, risk factors, treatment, prevention


Objective: To evaluate the different risk factors associated with breast cancer that affect commune IV of Valledupar/Cesar and to group them in order to determine the factors that have the highest incidence.

Material and Methods: A survey was applied to 120 women from the IV commune of Valledupar/ Cesar, Colombia; after the survey, they were provided with information on risk factors, what to do if they present one or more of these factors, and the importance of mammographic control and self-examination was explained to them.

Results: A total of 120 female respondents were included, the median age was 47 years (19-73 years). Excluding female sex (a risk factor present in all respondents), 100% of the respondents had one or more risk factors associated with breast cancer, the most common being heredity, sedentary lifestyle (overweight, lack of exercise), alcoholism and use of hormones as a planning method.

Conclusions: Hereditary factors, sedentary lifestyle, alcoholism and the use of hormones as a planning method are the most recurrent risk factors in commune IV of the city of Valledupar/Cesar, Colombia. It is necessary to instill a collective responsibility, aimed at changing bad habits in order to reduce the risk factors for breast cancer in this community. In addition, distinguishing these factors plays an important role in the prevention and treatment of the disease.

Abstract 85 | Pdf Downloads 43


1. De la Salud AM. Aplicación de la Agenda 2030 para el Desarrollo Sostenible: informe del Director General. Organización Mundial de la Salud; 2019.
2. Jiménez Ayala KJ, Vargas Ortiz N, Caro Romero S, Baquero Martinez WS, Jaramillo Díaz YL. Contextualización general de la salud pública. 2019;
3. Bosch FX, Coleman MP. Descriptive epidemiology. En: Manual of Clinical Oncology. Springer; 1982. p. 31-42.
4. Brunello A, Jirillo A, Falci C, Lonardi S, Basso U, Monfardini S. Treatment of advanced breast cancer in elderly women: medical approach. 2008;
5. Ordiales Cuesta O. Análisis de detección temprana del cáncer de mama. 2019;
6. Momenimovahed Z, Salehiniya H. Epidemiological characteristics of and risk factors for breast cancer in the world. Breast Cancer Targets Ther. 2019; 11:151.
7. Piñeros M, Sánchez R, Perry F, García OA, Ocampo R, Cendales R. Delay for diagnosis and treatment of breast cancer in Bogota, Colombia. Salud Publica Mex. 2011;53(6):478-85.
8. de Vries E, Arroyave I, Pardo C, Wiesner C, Murillo R, Forman D, et al. Trends in inequalities in premature cancer mortality by educational level in Colombia, 1998–2007. J Epidemiol Community Health. 2015;69(5):408-15.
9. Alcocer BS, Gutiérrez TJL, Rodriguez PGC, Canché BA, Caamal MEL, de Chavez-Figueroa MCR, et al. Cáncer de mama: factores de riesgo en mujeres: Breast cancer: risk factors in women. South Fla J Dev. 2022;3(4):4685-95.
10. Maffuz-Aziz A, Labastida-Almendaro S, Sherwell-Cabello S, Ruvalcaba-Limón E, Domínguez-Reyes CA, Tenorio-Torres JA, et al. Supervivencia de pacientes con cáncer de mama. Análisis por factores pronóstico, clínicos y patológicos. Ginecol Obstet México. 2017;84(08):498-506.
11. Wang F, Shu X, Meszoely I, Pal T, Mayer IA, Yu Z, et al. Overall mortality after diagnosis of breast cancer in men vs women. JAMA Oncol. 2019;5(11):1589-96.
12. Momenimovahed Z, Salehiniya H. Epidemiological characteristics of and risk factors for breast cancer in the world. Breast Cancer Targets Ther. 2019; 11:151.
13. García Penedo A. Tratamiento del cáncer de mama en pacientes de edad avanzada. 2022;
14. Manahan ER, Kuerer HM, Sebastian M, Hughes KS, Boughey JC, Euhus DM, et al. Consensus guidelines on genetic testing for hereditary breast cancer from the American Society of Breast Surgeons. Ann Surg Oncol. 2019;26(10):3025-31.
15. Kheira DD, Abdessamad DA, Fatima A, Fatima H, Amina C, Narimane H, et al. Epidemiological, Familial, and Biological Profile of Breast Cancer in a Population of Women in Oran. Egypt Acad J Biol Sci C Physiol Mol Biol. 2022;14(1):435-49.
16. Cardoso F, Kyriakides S, Ohno S, Penault-Llorca F, Poortmans P, Rubio IT, et al. Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2019;30(8):1194-220.
17. Thakur P, Seam RK, Gupta MK, Gupta M, Sharma M, Fotedar V. Breast cancer risk factor evaluation in a Western Himalayan state: A case-control study and comparison with the Western World. South Asian J Cancer. 2017;6(3):106-9.
18. Momenimovahed Z, Salehiniya H. Epidemiological characteristics of and risk factors for breast cancer in the world. Breast Cancer Targets Ther. 2019; 11:151-64.
19. Lohmann AE, Soldera SV, Pimentel I, Ribnikar D, Ennis M, Amir E, et al. Association of obesity with breast cancer outcome in relation to cancer subtypes: a meta-analysis. JNCI J Natl Cancer Inst. 2021;113(11):1465-75.
20. Britt KL, Cuzick J, Phillips KA. Key steps for effective breast cancer prevention. Nat Rev Cancer. 2020;20(8):417-36.
21. Asamblea Médica Mundial (Helsinki,1964), revisada por la 29na. Asamblea Médica Mundial (Tokio, 1975) y enmendada por la 35ta. Asamblea Médica Mundial (Venecia, 1983) y la 41era. Asamblea Médica Mundial (Hong Kong, 1989).
22. Benítez DB, Vigué J. Cáncer de mama (p. 31). Asklepios. 2012.
23. Farhat GN, Cummings SR, Chlebowski RT, Parimi N, Cauley JA,, Rohan TE et al. Sex hormone levels and risks of estrogen receptor-negative and estrogen receptor-positive breast cancers. J Natl Cancer Inst 2011; 103:562.